Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Science ; 365(6455): 817-820, 2019 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-31439797

RESUMO

The near-Earth asteroid (162173) Ryugu is a 900-m-diameter dark object expected to contain primordial material from the solar nebula. The Mobile Asteroid Surface Scout (MASCOT) landed on Ryugu's surface on 3 October 2018. We present images from the MASCOT camera (MASCam) taken during the descent and while on the surface. The surface is covered by decimeter- to meter-sized rocks, with no deposits of fine-grained material. Rocks appear either bright, with smooth faces and sharp edges, or dark, with a cauliflower-like, crumbly surface. Close-up images of a rock of the latter type reveal a dark matrix with small, bright, spectrally different inclusions, implying that it did not experience extensive aqueous alteration. The inclusions appear similar to those in carbonaceous chondrite meteorites.

2.
Opt Express ; 7(12): 427-35, 2000 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-19407894

RESUMO

An algorithm for correcting instrumental effects in polarization lidar studies is discussed. Cross-talk between the perpendicular and parallel polarization channels and imperfect polarization of the transmitted laser beam are taken into account. On the basis of the Mueller formalism it is shown that - with certain assumptions - the combined effects of imperfect polarization of the transmitted laser pulse, non-ideal properties of transmitter and receiver optics and cross-talk between parallel and perpendicular polarization channels can be described by a single parameter, which is essentially the overall system depolarization.

4.
Biometrics ; 50(3): 700-11, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7981396

RESUMO

Consider a pharmaceutical trial where the consequences of different decisions are expressed on a financial scale. The efficacy of the new drug under consideration has a prior distribution obtained from the underlying biological process, animal experiments, clinical experience, and so forth. Berry and Ho (Biometrics 44, 219-227) show how these components are used to establish an optimal (Bayes) sequential testing procedure, assuming a known constant sample size at each decision point. We show in this article how it is also possible to optimize further, with respect to the sample-size rule. This component of the design, which is missing from most sequential procedures, has the potential to yield considerably larger expected net gains (equivalently, considerably smaller Bayes risks).


Assuntos
Teorema de Bayes , Ensaios Clínicos como Assunto/métodos , Ensaios Clínicos Controlados como Assunto/métodos , Tratamento Farmacológico , Animais , Biometria , Humanos , Matemática
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA